Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with <i>Breast Cancer 2</i> (<i>BRCA2</i>) MutationChong Du, Yinmo Yang, Yingqiu Qi et al.|ACS Nano|2018Cited by 99
Clinicopathological characteristics and prognostic analysis of PIK3CA mutation in breast cancer patients in Northwest ChinaWei Lv, Shuqun Zhang, Yaofeng Jin et al.|Pathology - Research and Practice|2022Cited by 6